MSCRF Launch Program RFA Grant

The Maryland Stem Cell Research Fund (MSCRF) Launch Program aims to accelerate the commercialization of innovative technologies that leverage human stem cells or their derivatives. This initiative encourages collaboration between public and private sectors, promoting partnerships between research institutions and businesses in Maryland. By providing supplementary funding, the program seeks to enhance technology development, ensuring a pathway from research to market, thereby fostering significant advancements in healthcare.

The Maryland Stem Cell Research Fund (MSCRF) Commercialization Program was created to support translational activities necessary to advance technologies with significant commercial potential to a clinical-stage or to market, whether such technologies are therapeutic, diagnostic, enabling/supportive of human stem cells, or technologies involving human stem cell derivatives (including extracellular vesicles). Specifically, it is the intent of the Commercialization Program to foster the commercialization of such technologies.
It is also the intent of the Program to foster collaborations between the private and public sectors. With the strategic goal to enhance collaboration between research institutions and businesses in Maryland, the program provides an opportunity to access supplementary funding (“Second-tier Funding”) for advancing technology development in cases where there is potential for collaboration between n research institution and a commercial entity. To access the Second-tier Funding, the applicant must establish a collaborative relationship with a Maryland-based research institution through which specific research activities integral to the research project will be conducted in the research institution.